XEIA Venture Partners
Venture capitalActively deployingSan Francisco · 3 people tracked
Find your way into XEIA Venture Partners
393 people in our graph share verified history with the XEIA Venture Partners team — schools, employers, funds. One of them is your warm intro.
Investment thesis
XEIA Venture Partners pursues cross-disciplinary exploration, investment and acceleration, organized around a 'Human 3' theme concerning the future of health, wellbeing and performance. The firm backs early-stage startups and is notably open to founding teams that are romantic couples, having found several such teams among its highest-performing portfolio companies in its first fund. It invested in roughly 11 companies across 2024 and the first half of 2025 and has raised a first fund plus a first close on a second fund.
Source: firm website, verified Aug 3, 2026.
Team · 3 people
from the firm's website & curated
What they invest in
from 15 of 30 portfolio companiesBiotech ×10Deep Tech ×7Healthtech ×7Medical Devices ×5AI & Machine Learning ×4Digital Health ×4Mental Health ×4Longevity ×2
HQs:United States×9Australia×2Mexico×1
Investments · 30 tracked
founders shown can be your intro pathBy year:2025 · 22024 · 12021 · 14 dated
Vonova develops the Cerebro Platform, a minimally invasive neurovascular system that uses the body's venous system to access the brain, guided by real-time imaging to deliver diagnostic and therapeutic treatments without drilling through the skull.
Deep TechHealthtechMedical Devices
José Morales(Dr.)
Co-investorsSmartGateVC
Aperture Therapeutics uses machine learning to mine genomic and clinical datasets for naturally occurring protective gene variants, then designs oligonucleotide therapeutics that mimic those variants to treat neurodegenerative diseases such as ALS and FTD and delay brain aging.
AI & Machine LearningBiotechLongevity
Martin Jacko(Founder & CEO)in
Co-investorsage1
Beond operates a medically supervised ibogaine treatment facility in Mexico that uses neuroplasticity-focused therapies to treat depression, anxiety, PTSD, trauma, TBI, and substance addictions such as opioids, fentanyl, stimulants, and alcohol use disorder.
HealthtechMental HealthWellness & Fitness
Coherence develops neurotechnology systems that measure and modulate brain activity to treat cancer and other neurological diseases.
AI & Machine LearningBiotechMedical DevicesSan Francisco, US
Ben Woodington(Co-founder & CEO)inElise Jenkins(Co-founder & CTO)in
Co-investorsArtesianBlackbird VenturesPossible VenturesSmartGateVCDivergent CapitalSciFounders+1 more
The page references health, wellbeing and performance under the banner "Human 3," alongside expertise in AI/ML, medicinal chemistry/pharmacology, and aging-brain research.
AI & Machine LearningLongevityWellness & FitnessSan Francisco, US
Lycos PBC develops investigational psychedelic-based therapeutics to treat mental health conditions, with an initial focus on post-traumatic stress disorder.
BiotechDeep TechMental Health
Co-investorsJourneyOne VenturesLauder PartnersLeafy TunnelSolari CapitalWGD Capital, L.P.
Mindstate Design Labs is a clinical-stage drug development company that uses AI to map the biological basis of emotion and cognition, synthesizing psychedelic phenomenology and biochemical data to design pharmaceutical compounds that induce specific therapeutic emotional and cognitive states for mental health treatment.
AI & Machine LearningBiotechHealthtechMental HealthSan Francisco, US
Dillan DiNardo(Founder/CEO)inTom Ray(Founder)in
BoardRand Hindi(Director)in
Co-investorsImmeasurableMetaplanetPsyMed VenturesY CombinatorDay One VenturesInitialized Capital+3 more
Motif Neurotech develops a therapeutic brain-computer interface using minimally invasive neuromodulation to treat difficult-to-treat mental health conditions such as depression.
BiotechDeep TechDigital HealthHealthtechMedical DevicesHouston, US
Sameer Sheth(Founder)inSunil Sheth(Founder)Nick Halper(Chief Operating Officer)inSteve Goetz(Chief Technology Officer)inAnthony Arnold(Director)in
BoardJacob Robinson(Co-founder & CEO)in
Co-investorsArboretum VenturesFeatures Capital HoldingsPsyMed VenturesTMC Venture FundCapital FactoryDivergent Capital+4 more
NeuroBionics develops soft, flexible neural interface technologies for neuromodulation applications.
BiotechDeep TechHealthtechMedical DevicesSomerville, US
MJ Antonini(Founder, CEO)inNicki Driscoll(Founder, CTO)Polina Anikeeva(Founder)in
Co-investorsFuture VenturesGreyMatterVanedge CapitalVanedge Capital Limited PartnershipDolby Family VenturesLIONHEART VENTURES
Pangea Bio develops therapies targeting central nervous system and mental health disorders by activating the TrkB receptor pathway to promote neuronal survival and synaptic plasticity.
BiotechDeep TechDigital Health
Co-investorsMetaplanetNO LABEL VENTURESSeaside VenturesVox Capital
Platform accelerating drug discovery for untreatable diseases.
BiotechDedham, US
Samantha Dale Strasser(Director)Jon (Yu) Hu(Founder)inYu Hu(Executive Officer, Director)
BoardOmri Amirav-Drory(Director)in
Co-investorsbig_betsSilverton PartnersMana VenturesNFXVSC Ventures
TARA Mind offers a specialized, clinician-guided mental health benefit that employers add to their existing benefits to serve workers with treatment-resistant conditions, connecting them to a vetted U.S. network of therapists and physicians for evidence-based care.
Digital HealthHR TechMental Health
Marcus Capone(Founder & CEO)in
Co-investorsRed Cell IncubationPrime Movers Lab
Ultra Bionics develops implantable focused ultrasound technology placed inside the skull to deliver targeted, adaptive neuromodulation for treating neurological diseases, beginning with Parkinson's disease.
Deep TechHealthtechMedical DevicesMelbourne, AU
Xylo develops mechanism-based drug therapies targeting psychiatric and neurological disorders using computational and rational drug design approaches.
BiotechDeep TechDigital HealthHealthtechSydney, AU
Joshua Ismin(Co-founder, President)inDr. Sam Banister(Co-founder, Chief Scientific Officer)
Co-investorsRadar VenturesCapitalTCommon MagicSure Valley Ventures
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
ApertureBeondBiosphereForecast BioFreedomKadenceKerna LabsLykosMotifMycrodose TherapeuticsPangeaPodcastSuperpowerSynchronTippingPointWonder
Portfolio news
latest coverage across their companiesPangea Bio · cambridgebiocapital.substack.com · Jul 21, 2026
Xylo · priyalifescience.com · Jul 5, 2026
Coherence Neuro · massdevice.com · Jun 25, 2026
NeuroBionics · newmarketpitch.com · Feb 18, 2026
Motif Neurotech · businesswire.com · Dec 16, 2025
Vonova · med-tech.world · Jun 23, 2025
Frequently asked questions
- How many investments has XEIA Venture Partners made?
- XEIA Venture Partners has 30 tracked investments, including 2 dated in the last 24 months.
- What sectors does XEIA Venture Partners focus on?
- XEIA Venture Partners focuses on AI & Machine Learning, Biotech, Deep Tech, Hardware, Healthtech, Longevity, Wellness & Fitness.
- Where is XEIA Venture Partners located?
- XEIA Venture Partners is headquartered in San Francisco, US.
- Who does XEIA Venture Partners co-invest with?
- XEIA Venture Partners most often shares deals with SmartGateVC, Arboretum Ventures, Blackbird Ventures, among 15 tracked co-investors.
Images
Co-investors · 2
Four Acres is an early-stage venture capital fund founded by native New Yorkers, focused on software-first technology companies.
Investment firm focused on emerging public and private companies in agriculture, consumer, healthcare, and technology sectors, leveraging deep expertise in small-cap markets.
Firms observed investing alongside XEIA Venture Partners, from public investor directories. Shared companies are the overlap with XEIA Venture Partners's recorded portfolio.
Similar investors
Lauder Partners, LLC is a technology-focused investment entity that invests both directly in companies and in funds (venture and other), primarily deploying the capital of Gary Lauder and his family.
Everywhere Ventures is an early-stage venture firm, backed by a community of founders and operators as LPs, that writes early checks (including pre-seed) into startups across many sectors and geographies.
Anthropy Partners is an investment firm backing founders building technologies that extend the capabilities of the human body and mind, focused on what it calls the 'long-human era'.
Embryo Ventures is an early-stage venture firm backing founders building technologies across human health and human experience, from clinical and consumer health to essential life infrastructure.
Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.